Monthly Revenue From ScripsAmerica's Managed Specialty Pharmacy Nearly Doubles in April, Topping $958,000
May 05 2014 - 8:30AM
ScripsAmerica, Inc. (OTCBB:SCRC) today announced
that its managed specialty pharmacy reported $958,234 in
prescription sales during the month of April, representing a 94%
increase in monthly revenue over March.
The specialty pharmacy, which focuses on compounding topical
creams, has generated a total of $1,600,501 in sales since
ScripsAmerica entered an agreement to manage its operations in
exchange for a very significant percentage of its revenues in
February. April's figures give the pharmacy an annual run rate of
$11.5 million.
Bob Schneiderman, the Company's CEO, stated, "We are very
pleased to report that ScripsAmerica's managed specialty pharmacy
set a revenue record in April, nearly doubling its sales from
March. This demonstrates significant rapid revenue growth and
further, we believe that the Company has not nearly tapped the
potential of this endeavor. There are several factors that we
believe will drive steady revenue growth for this pharmacy."
"First, topical creams are experiencing growing demand as an
effective alternative to pills that can be more easily ingested in
higher doses than originally prescribed. Secondly, our pharmacy
utilizes a new system to process prescriptions that have greatly
increased its efficiency, sales, profitability, etc. Finally, under
our management, the specialty pharmacy has applied for licensing in
additional states, which will enable continued growth in both our
revenues and profits from this operation," continued
Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and
nutraceutical drugs, delivering pharmaceutical products to a wide
range of end users across the health care industry. End users
include retail pharmacies, hospitals, long-term care facilities and
government and home care agencies. For more information, visit
www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
CONTACT: 888-959-7095
ir@sealpointconsulting.com
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Aug 2024 to Sep 2024
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Sep 2023 to Sep 2024